Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
Shock (Augusta, Ga.)
|
November 26, 2014
Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage
Shirley Owusu-Ofori, Joseph Kusi, Alex Owusu-Ofori, et al.
Transfusion
|
March 23, 2016
Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro
Andrew P Cap, Heather F Pidcoke, Shawn D Keil, et al.
Vaccines
|
February 26, 2026
Dose-Dependent Efficacy of a Riboflavin and Ultraviolet Light-Inactivated Whole-Virion SARS-CoV-2 Vaccine in a Hamster Infection Challenge Model
Noelia Altina, Izabela K Ragan, Kimberly A Arnett, et al.
Vaccines
|
April 30, 2021
A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model
Izabela K Ragan, Lindsay M Hartson, Taru S Dutt, et al.
Transfusion
|
January 11, 2013
Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time
Heather F Pidcoke, Steve J McFaul, Anand K Ramasubramanian, et al.
Blood
|
May 19, 2018
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
Pieter F van der Meer, Paula F Ypma, Nan van Geloven, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
Shock (Augusta, Ga.)
|
November 26, 2014
Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage
Shirley Owusu-Ofori, Joseph Kusi, Alex Owusu-Ofori, et al.
Transfusion
|
March 23, 2016
Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro
Andrew P Cap, Heather F Pidcoke, Shawn D Keil, et al.
Vaccines
|
February 26, 2026
Dose-Dependent Efficacy of a Riboflavin and Ultraviolet Light-Inactivated Whole-Virion SARS-CoV-2 Vaccine in a Hamster Infection Challenge Model
Noelia Altina, Izabela K Ragan, Kimberly A Arnett, et al.
Vaccines
|
April 30, 2021
A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model
Izabela K Ragan, Lindsay M Hartson, Taru S Dutt, et al.
Transfusion
|
January 11, 2013
Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time
Heather F Pidcoke, Steve J McFaul, Anand K Ramasubramanian, et al.
Blood
|
May 19, 2018
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
Pieter F van der Meer, Paula F Ypma, Nan van Geloven, et al.
Page
of 7